Andrew Cline /
1 February 2017Americas

Trump to ‘streamline’ the FDA and lower drug prices

US President Donald Trump has said that he intends to lower drug prices and speed up the Food and Drug Administration (FDA) approval process for new drugs.

According to a press release published by the White House yesterday, January 31, highlighting the president’s “listening session” with pharmaceutical industry leaders, Trump said: “For Medicare, for Medicaid, we have to get the prices way down, so that's what we're going to be talking about.”

He added that he is going to be streamlining the process of getting drugs approved.

Trump explained that he is going to “get rid of [the] tremendous number of regulations”.

In the session, Trump also talked about appointing a new leader to streamline the FDA in order to speed up the process of drug approval.

The person was not revealed, but Trump said that he will be naming the person “fairly soon”.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at